En bloc resection of bladder tumour: the rebirth of past through reminiscence

Jeremy Yuen-Chun Teoh; David D'Andrea; Andrea Gallioli; Takafumi Yanagisawa; Steven MacLennan; Rossella Nicoletti; Ng Chi Fai; Davide Maffei; Rodolfo Hurle; Lukas Lusuardi; Bernard Malavaud; Jun Miki; Mario Kramer; Hugh Mostafid; Dmitry Enikeev; Marek Babjuk; Alberto Breda; Shahrokh Shariat; Paolo Gontero; Thomas Herrmann

doi:10.1007/s00345-023-04547-0

En bloc resection of bladder tumour: the rebirth of past through reminiscence

Jeremy Yuen-Chun Teoh^* (Corresponding Author), David D'Andrea, Andrea Gallioli, Takafumi Yanagisawa, Steven MacLennan, Rossella Nicoletti, Ng Chi Fai, Davide Maffei, Rodolfo Hurle, Lukas Lusuardi, Bernard Malavaud, Jun Miki, Mario Kramer, Hugh Mostafid, Dmitry Enikeev, Marek Babjuk, Alberto Breda, Shahrokh Shariat, Paolo Gontero, Thomas Herrmann

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

Abstract

PURPOSE: To learn about the history and development of en bloc resection of bladder tumour (ERBT), and to discuss its future directions in managing bladder cancer.

METHODS: In this narrative review, we summarised the history and early development of ERBT, previous attempts in overcoming the tumour size limitation, consolidative effort in standardising the ERBT procedure, emerging evidence in ERBT, evolving concepts in treating large bladder tumours, and the future directions of ERBT.

RESULTS: Since the first report on ERBT in 1980, there has been tremendous advancement in terms of its technique, energy modalities and tumour retrieval methods. In 2020, the international consensus statement on ERBT has been developed and it serves as a standard reference for urologists to practise ERBT. Recently, high-quality evidence on ERBT has been emerging. Of note, the EB-StaR study showed that ERBT led to a reduction in 1-year recurrence rate from 38.1 to 28.5%. An individual patient data meta-analysis is currently underway, and it will be instrumental in defining the true value of ERBT in treating non-muscle-invasive bladder cancer. For large bladder tumours, modified approaches of ERBT should be accepted, as the quality of resection is more important than a mere removal of tumour in one piece. The global ERBT registry has been launched to study the value of ERBT in a real-world setting.

CONCLUSION: ERBT is a promising surgical technique in treating bladder cancer and it has gained increasing interest globally. It is about time for us to embrace this technique in our clinical practice.

Original language	English
Pages (from-to)	2599-2606
Number of pages	8
Journal	World Journal of Urology
Volume	41
Issue number	10
Early online date	16 Aug 2023
DOIs	https://doi.org/10.1007/s00345-023-04547-0
Publication status	Published - Oct 2023

Keywords

Humans
Cystectomy/methods
Urinary Bladder/pathology
Urinary Bladder Neoplasms/surgery
Meta-Analysis as Topic

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00345-023-04547-0Licence: CC BY

Teoh_Etal_WJU_En_Bloc_Resection_VOR
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Final published version, 1.22 MBLicence: CC BY

Cite this

Teoh, J. Y.-C., D'Andrea, D., Gallioli, A., Yanagisawa, T., MacLennan, S., Nicoletti, R., Fai, N. C., Maffei, D., Hurle, R., Lusuardi, L., Malavaud, B., Miki, J., Kramer, M., Mostafid, H., Enikeev, D., Babjuk, M., Breda, A., Shariat, S., Gontero, P., & Herrmann, T. (2023). En bloc resection of bladder tumour: the rebirth of past through reminiscence. World Journal of Urology, 41(10), 2599-2606. https://doi.org/10.1007/s00345-023-04547-0

Teoh, JY-C, D'Andrea, D, Gallioli, A, Yanagisawa, T, MacLennan, S, Nicoletti, R, Fai, NC, Maffei, D, Hurle, R, Lusuardi, L, Malavaud, B, Miki, J, Kramer, M, Mostafid, H, Enikeev, D, Babjuk, M, Breda, A, Shariat, S, Gontero, P & Herrmann, T 2023, 'En bloc resection of bladder tumour: the rebirth of past through reminiscence', World Journal of Urology, vol. 41, no. 10, pp. 2599-2606. https://doi.org/10.1007/s00345-023-04547-0

@article{80ff40a97fba492da0c99cde53c48e00,

title = "En bloc resection of bladder tumour: the rebirth of past through reminiscence",

abstract = "PURPOSE: To learn about the history and development of en bloc resection of bladder tumour (ERBT), and to discuss its future directions in managing bladder cancer.METHODS: In this narrative review, we summarised the history and early development of ERBT, previous attempts in overcoming the tumour size limitation, consolidative effort in standardising the ERBT procedure, emerging evidence in ERBT, evolving concepts in treating large bladder tumours, and the future directions of ERBT.RESULTS: Since the first report on ERBT in 1980, there has been tremendous advancement in terms of its technique, energy modalities and tumour retrieval methods. In 2020, the international consensus statement on ERBT has been developed and it serves as a standard reference for urologists to practise ERBT. Recently, high-quality evidence on ERBT has been emerging. Of note, the EB-StaR study showed that ERBT led to a reduction in 1-year recurrence rate from 38.1 to 28.5%. An individual patient data meta-analysis is currently underway, and it will be instrumental in defining the true value of ERBT in treating non-muscle-invasive bladder cancer. For large bladder tumours, modified approaches of ERBT should be accepted, as the quality of resection is more important than a mere removal of tumour in one piece. The global ERBT registry has been launched to study the value of ERBT in a real-world setting.CONCLUSION: ERBT is a promising surgical technique in treating bladder cancer and it has gained increasing interest globally. It is about time for us to embrace this technique in our clinical practice.",

keywords = "Humans, Cystectomy/methods, Urinary Bladder/pathology, Urinary Bladder Neoplasms/surgery, Meta-Analysis as Topic",

author = "Teoh, {Jeremy Yuen-Chun} and David D'Andrea and Andrea Gallioli and Takafumi Yanagisawa and Steven MacLennan and Rossella Nicoletti and Fai, {Ng Chi} and Davide Maffei and Rodolfo Hurle and Lukas Lusuardi and Bernard Malavaud and Jun Miki and Mario Kramer and Hugh Mostafid and Dmitry Enikeev and Marek Babjuk and Alberto Breda and Shahrokh Shariat and Paolo Gontero and Thomas Herrmann",

year = "2023",

month = oct,

doi = "10.1007/s00345-023-04547-0",

language = "English",

volume = "41",

pages = "2599--2606",

journal = "World Journal of Urology",

issn = "0724-4983",

publisher = "Springer Verlag",

number = "10",

}

TY - JOUR

T1 - En bloc resection of bladder tumour

T2 - the rebirth of past through reminiscence

AU - Teoh, Jeremy Yuen-Chun

AU - D'Andrea, David

AU - Gallioli, Andrea

AU - Yanagisawa, Takafumi

AU - MacLennan, Steven

AU - Nicoletti, Rossella

AU - Fai, Ng Chi

AU - Maffei, Davide

AU - Hurle, Rodolfo

AU - Lusuardi, Lukas

AU - Malavaud, Bernard

AU - Miki, Jun

AU - Kramer, Mario

AU - Mostafid, Hugh

AU - Enikeev, Dmitry

AU - Babjuk, Marek

AU - Breda, Alberto

AU - Shariat, Shahrokh

AU - Gontero, Paolo

AU - Herrmann, Thomas

PY - 2023/10

Y1 - 2023/10

N2 - PURPOSE: To learn about the history and development of en bloc resection of bladder tumour (ERBT), and to discuss its future directions in managing bladder cancer.METHODS: In this narrative review, we summarised the history and early development of ERBT, previous attempts in overcoming the tumour size limitation, consolidative effort in standardising the ERBT procedure, emerging evidence in ERBT, evolving concepts in treating large bladder tumours, and the future directions of ERBT.RESULTS: Since the first report on ERBT in 1980, there has been tremendous advancement in terms of its technique, energy modalities and tumour retrieval methods. In 2020, the international consensus statement on ERBT has been developed and it serves as a standard reference for urologists to practise ERBT. Recently, high-quality evidence on ERBT has been emerging. Of note, the EB-StaR study showed that ERBT led to a reduction in 1-year recurrence rate from 38.1 to 28.5%. An individual patient data meta-analysis is currently underway, and it will be instrumental in defining the true value of ERBT in treating non-muscle-invasive bladder cancer. For large bladder tumours, modified approaches of ERBT should be accepted, as the quality of resection is more important than a mere removal of tumour in one piece. The global ERBT registry has been launched to study the value of ERBT in a real-world setting.CONCLUSION: ERBT is a promising surgical technique in treating bladder cancer and it has gained increasing interest globally. It is about time for us to embrace this technique in our clinical practice.

AB - PURPOSE: To learn about the history and development of en bloc resection of bladder tumour (ERBT), and to discuss its future directions in managing bladder cancer.METHODS: In this narrative review, we summarised the history and early development of ERBT, previous attempts in overcoming the tumour size limitation, consolidative effort in standardising the ERBT procedure, emerging evidence in ERBT, evolving concepts in treating large bladder tumours, and the future directions of ERBT.RESULTS: Since the first report on ERBT in 1980, there has been tremendous advancement in terms of its technique, energy modalities and tumour retrieval methods. In 2020, the international consensus statement on ERBT has been developed and it serves as a standard reference for urologists to practise ERBT. Recently, high-quality evidence on ERBT has been emerging. Of note, the EB-StaR study showed that ERBT led to a reduction in 1-year recurrence rate from 38.1 to 28.5%. An individual patient data meta-analysis is currently underway, and it will be instrumental in defining the true value of ERBT in treating non-muscle-invasive bladder cancer. For large bladder tumours, modified approaches of ERBT should be accepted, as the quality of resection is more important than a mere removal of tumour in one piece. The global ERBT registry has been launched to study the value of ERBT in a real-world setting.CONCLUSION: ERBT is a promising surgical technique in treating bladder cancer and it has gained increasing interest globally. It is about time for us to embrace this technique in our clinical practice.

KW - Humans

KW - Cystectomy/methods

KW - Urinary Bladder/pathology

KW - Urinary Bladder Neoplasms/surgery

KW - Meta-Analysis as Topic

U2 - 10.1007/s00345-023-04547-0

DO - 10.1007/s00345-023-04547-0

M3 - Review article

C2 - 37584691

SN - 0724-4983

VL - 41

SP - 2599

EP - 2606

JO - World Journal of Urology

JF - World Journal of Urology

IS - 10

ER -

En bloc resection of bladder tumour: the rebirth of past through reminiscence

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this